Aurinia Pharm Ord (NQ: AUPH )

15.19 USD +0.17 (+1.13%)

Official Closing Price Updated: 5:00 PM EDT, Oct 22, 2020 Add to My Watchlist

Price and Volume

Volume	353,878
Open	14.95
Bid (Size)	15.19 (1)
Ask (Size)	15.29 (1)
Prev. Close	15.02
Today's Range	14.89 - 15.39
52wk Range	4.570 - 21.93
Shares Outstanding	84,478,054
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020

Today 16:15 EDT

Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today...

Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com

October 14, 2020

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced Time Is Nephrons, the first-ever lupus nephritis (LN) disease-state awareness campaign for healthcare...

Performance

YTD	-29.22%	-29.22%
1 Month	+1.61%	+1.61%
3 Month	-8.82%	-8.82%
6 Month	-5.71%	-5.71%
1 Year	+203.19%	+203.19%

More News

Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 02, 2020

Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome

September 28, 2020

Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences

September 10, 2020

Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 04, 2020

Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights

August 11, 2020

Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

August 04, 2020

Short Interest Ratio Indicates Bullish Canadian Stocks: $PAAS $REAL $AUP

August 05, 2020

Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020

July 30, 2020

Aurinia Closes US$200 Million Public Offering of Common Shares

July 27, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.